Replacement of bortezomib with carfilzomib for multiple myeloma patients progressing from bortezomib combination therapy.
Berenson JR et al. Leukemia. 2014 Jan 16. doi: 10.1038/leu.2014.27. [Epub ahead of print].
Immunotherapy for multiple myeloma.
Rosenblatt J et al. Expert Rev Hematol. 2014 Jan 13. [Epub ahead of print].
Phase I study of MLN8237-investigational Aurora A kinase inhibitor-in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Kelly KR et al. Invest New Drugs. 2013 Dec 20. [Epub ahead of print].
